CA2018573A1 - Preparation lyophilisee de la 6-(3-dimethylaminopropionyl) forskoline - Google Patents

Preparation lyophilisee de la 6-(3-dimethylaminopropionyl) forskoline

Info

Publication number
CA2018573A1
CA2018573A1 CA2018573A CA2018573A CA2018573A1 CA 2018573 A1 CA2018573 A1 CA 2018573A1 CA 2018573 A CA2018573 A CA 2018573A CA 2018573 A CA2018573 A CA 2018573A CA 2018573 A1 CA2018573 A1 CA 2018573A1
Authority
CA
Canada
Prior art keywords
lyophilized preparation
dimethylaminopropionyl
forskolin
lyophilized
resolubility
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2018573A
Other languages
English (en)
Other versions
CA2018573C (fr
Inventor
Emiko Yamasaki
Takaaki Ohkuma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Kayaku Co Ltd
Original Assignee
Nippon Kayaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Kayaku Co Ltd filed Critical Nippon Kayaku Co Ltd
Publication of CA2018573A1 publication Critical patent/CA2018573A1/fr
Application granted granted Critical
Publication of CA2018573C publication Critical patent/CA2018573C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/92—Naphthopyrans; Hydrogenated naphthopyrans

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyrane Compounds (AREA)
CA002018573A 1989-06-15 1990-06-08 Preparation lyophilisee de la 6-(3-dimethylaminopropionyl) forskoline Expired - Fee Related CA2018573C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP15059589 1989-06-15
JP01-150595 1989-06-15

Publications (2)

Publication Number Publication Date
CA2018573A1 true CA2018573A1 (fr) 1990-12-15
CA2018573C CA2018573C (fr) 1998-12-01

Family

ID=15500318

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002018573A Expired - Fee Related CA2018573C (fr) 1989-06-15 1990-06-08 Preparation lyophilisee de la 6-(3-dimethylaminopropionyl) forskoline

Country Status (13)

Country Link
US (1) US5051132A (fr)
EP (1) EP0402805B1 (fr)
JP (1) JPH06102625B2 (fr)
KR (1) KR0138104B1 (fr)
AU (1) AU625369B2 (fr)
CA (1) CA2018573C (fr)
CZ (1) CZ280278B6 (fr)
DE (1) DE69003178T2 (fr)
ES (1) ES2059889T3 (fr)
HU (1) HU206619B (fr)
PL (1) PL164449B1 (fr)
RU (2) RU1836080C (fr)
TW (1) TW199104B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005004842A2 (fr) 2003-06-30 2005-01-20 Alza Corporation Formulations pour microprojections revetues contenant des contre-ions non volatils

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2149304A (en) * 1936-04-20 1939-03-07 Sharp & Dohme Inc Lyophilic biologically active substances
GB1357731A (en) * 1970-02-12 1974-06-26 Ethichem Ltd Free flowing powder compositions and ointments containing them'
US4517200A (en) * 1982-12-27 1985-05-14 Schering-Plough Corporation Method for treating allergic reactions with forskolin
JPS59193831A (ja) * 1983-04-18 1984-11-02 Sankyo Co Ltd 腸溶性製剤の製造法
US4804548A (en) * 1984-10-05 1989-02-14 Warner-Lambert Company Novel sweetener delivery systems
DE3581725D1 (de) * 1984-12-14 1991-03-14 Hoechst Roussel Pharma Aminoacyllabdane, verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung als arzneimittel.
DE3678736D1 (de) * 1985-03-01 1991-05-23 Hoechst Roussel Pharma Labdanderivate, verfahren zu deren herstellung und deren verwendung als arzneimittel.
AU591196B2 (en) * 1985-11-15 1989-11-30 Nippon Kayaku Kabushiki Kaisha Novel forskolin derivatives
US4956391A (en) * 1988-08-17 1990-09-11 Sapse Alfred T Protected complex of procaine for the treatment of symptoms from narcotics addiction, tinnitus and alzheimer's disease
US4936074A (en) * 1988-11-17 1990-06-26 D. M. Graham Laboratories, Inc. Process for preparing solid encapsulated medicament

Also Published As

Publication number Publication date
DE69003178T2 (de) 1994-03-10
EP0402805B1 (fr) 1993-09-08
HUT59309A (en) 1992-05-28
CA2018573C (fr) 1998-12-01
JPH06102625B2 (ja) 1994-12-14
CS9002968A2 (en) 1991-11-12
KR910000164A (ko) 1991-01-29
RU2095061C1 (ru) 1997-11-10
HU903849D0 (en) 1990-11-28
DE69003178D1 (de) 1993-10-14
AU5700690A (en) 1990-12-20
US5051132A (en) 1991-09-24
CZ280278B6 (cs) 1995-12-13
EP0402805A1 (fr) 1990-12-19
HU206619B (en) 1992-12-28
RU1836080C (ru) 1993-08-23
KR0138104B1 (ko) 1998-05-15
TW199104B (fr) 1993-02-01
ES2059889T3 (es) 1994-11-16
PL285504A1 (en) 1991-02-11
PL164449B1 (en) 1994-07-29
AU625369B2 (en) 1992-07-09
JPH0386820A (ja) 1991-04-11

Similar Documents

Publication Publication Date Title
CA2011171A1 (fr) Poly(esters phosphoriques) biodegradables
AU3074289A (en) 2,2'-iminobisethanol derivatives as potentiators of the effects of blood pressure reducing agents
IE902382L (en) Oat soluble dietary fiber compositions
CA2265767A1 (fr) Compositions medicinales stables, contenant des derives de 4,5-epoxymorphinane
EP0413953A3 (en) Copolymer as thickening agent in aqueous preparations active at a ph 5,5, process of its preparation and its use as thickening agent
AU1226492A (en) Optically active 5h-pyrrolo(3,4-b)pyrazine derivative, its preparation and pharmaceutical compositions containing same
CA2022177A1 (fr) Arginine deiminase, methode de production, et agent anti-cancereux contenant cette enzyme comme ingredient efficace
AU3481289A (en) Immunostimulating 7-deaza-7-oxa- and 7-deaza-7-thia- analogs of 8-substituted-guanine-9-(1'beta-d-aldoglycosidyl) derivatives, compositions and methods
CA2019812A1 (fr) Nouveau 5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-ones et leur utilisation dans la prevention et le traitement du sida
CA2018229A1 (fr) Composition de carboplatine
CA2176223A1 (fr) Formulations a base de fenbendazole
CA2063273A1 (fr) Surfactants pulmonaires et methodes
CA2127472A1 (fr) Nouveaux derives de l'adenosine; methodes de preparation; compositions pharmaceutiques a base de ces derives
AU1939388A (en) Water-soluble active methylenes as formaldehyde scavengers
AU7544787A (en) Synthetic alkali metal alumino-silicates, methods and uses, compositions and their methods of preparation
Currie Morphology and systematics of primitive Simuliidae (Diptera: Culicomorpha)
AU2636788A (en) Monoazo pigments, preparation and use thereof
CA2018573A1 (fr) Preparation lyophilisee de la 6-(3-dimethylaminopropionyl) forskoline
AU7294094A (en) Substituted 6,11-ethano-6,11-dihydrobenzo(b) quinolizinium salts and compositions and methods of use thereof
AU2171888A (en) 4-oxo-3-quinolinecarboxylic acids useful as antibacterial agents and preparation thereof
CA2055257A1 (fr) Saccharide comme source d'energie pour un organisme vivant et ses usages
NZ229023A (en) 1,1-dioxo-cephem-4-carbothiolic acid derivatives, pharmaceutical compositions and methods of preparation
EP0375031A3 (fr) Produits alimentaires à basses calories
AU2676988A (en) Malate composition and preparation of malates and 2,2'-oxodisuccinates useful as laundry detergents
AU2184388A (en) 4-oxo-3-quinolinecarboxylic acids useful as antibacterial agents and preparation thereof

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed